Osimertinib
Product name:Osimertinib
CAS No.:1421373-65-0
MF:C28H33N7O2
MW:499.61
EINECS No.629-848-5
Grade:Pharma grade
CAS No.:1421373-65-0
MF:C28H33N7O2
MW:499.61
EINECS No.629-848-5
Grade:Pharma grade
AP162
Quantity
![]()

Osimertinib is a targeted therapeutic agent belonging to the class of third representative tyrosine kinase
inhibitors of skin growth factor receptor (EGFR). It is primarily used to treat patients with EGFR
gene mutation-positive non-small cell lung cancer (NSCLC), especially those with advanced NSCLC
with the T790M mutation.
The mechanism of action of osimertinib is to prevent the growth and spread of cancer cells by inhibiting
the activity of EGFR kinase.
![]()
Osimertinib is an important targeted therapy with significant efficacy in EGFR mutation-positive NSCLC patients



